Renal Cancer - Results from #1640

Salvage nivolumab and ipilimumab after prior anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma: A meta-analysis. February 11, 2022

PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma. February 10, 2022

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional, Propensity Score Matching Cohort Study. February 9, 2022

Efficacy and Safety of First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. February 9, 2022

Soluble PD-L1 as an early marker of progressive disease on nivolumab. February 9, 2022

Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC). February 8, 2022

Update on the treatment of metastatic renal cell carcinoma. February 8, 2022

Zero ischemia laparoscopic microwave ablation assisted enucleation vs. laparoscopic partial nephrectomy in clinical T1a renal tumor: a randomized clinical trial. February 7, 2022

The changing trends of image-guided biopsy of small renal masses before intervention-an analysis of European multinational prospective EuRECA registry. February 7, 2022

Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature. February 4, 2022

Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma. February 4, 2022

Improving accuracy, reliability, and efficiency of the RENAL nephrometry score with 3D reconstructed virtual imaging. February 3, 2022

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival. February 3, 2022

The Role of Lymph Node Dissection for Non-Metastatic Renal Cell Carcinoma: An Updated Systematic Review and Meta-Analysis. February 2, 2022

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma. February 2, 2022

The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma. February 1, 2022

Utilizing head-mounted eye trackers to analyze patterns and decision-making strategies of 3D virtual modelling platform (IRIS™) during preoperative planning for renal cancer surgeries. February 1, 2022

Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma. January 31, 2022

Prognostic and Clinicopathological Correlations of Pretreatment Prognostic Nutritional Index in Renal Cell Carcinoma: A Meta-Analysis. January 31, 2022

MicroRNA-155-5p targets NR3C2 to promote malignant progression of clear cell renal cell carcinoma. January 28, 2022

Page 83 of 456